Facts About Paniculoside I Revealed
All enrolled patients who received not less than a single dose of zosuquidar or placebo in the course of induction ended up monitored with the incidence of adverse events (439 clients, 219 on zosuquidar and 210 on placebo). The commonest adverse events ended up related to the duration of extended and major myelosuppression as is expected with induc